Neurologix, Inc. NRGX.OB is a clinical stage biotechnology company dedicated to the discovery, development, and commercialization of life altering gene transfer therapies for serious disorders of the brain and Central Nervous System CNS .
Quote | Neurologix Inc (OTCMKTS:NRGXQ)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.000001 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Neurologix Inc (OTCMKTS:NRGXQ)
Axovant Sciences Ltd ( AXON ) is approaching two key catalysts which may attract the attention of the markets. When I last wrote about the company , I noted that I didn't like the decisions being made at AXON. Throughout 2019 we may begin to see if the company's risky decision, to pivot into ...
Message Board Posts | Neurologix Inc (OTCMKTS:NRGXQ)
Subject | By | Source | When |
---|---|---|---|
NRGXQ registration revoked: | Renee | investorshub | 04/29/2019 1:37:54 PM |
NRGXQ SEC Suspension for severely delinquent Financials/Filings: | Renee | investorshub | 09/15/2017 1:36:19 PM |
Emylers: NRGXQ Financials 07/16/2014 01:37:10 Neurologix, Inc. Period Ending Dec 31, 2010 Total Reve | Emylers | investorshangout | 07/16/2014 6:37:07 AM |
Stock_Tracker: Latest Neurologix Inc (NRGXQ) Headlines Retrophin Names Marc L. Panoff as Chief Finan | Stock_Tracker | investorshangout | 03/10/2014 11:51:42 PM |
chartguy89: NRGXQ 0.01 Stock Charts $NRGXQ 1 Month Chart | chartguy89 | investorshangout | 03/09/2014 3:50:21 AM |
News, Short Squeeze, Breakout and More Instantly...